Fineline Cube

Follow:
14691 Articles
CompanyDeals

Yunnan Jianzhijia Plans Acquisition of Hebei Tangren Pharmacy in USD 309 Million Deal

Policy / Regulatory

Sun Pharma Loses VBP Bid for Bicalutamide in China Due to Quality Failures

CompanyDrug

Allist Pharmaceuticals’ Furmonertinib Receives NMPA Approval for First-Line NSCLC Treatment

CompanyDeals

Dakang Medical Secures RMB 400M in Series E Round for Hemodialysis Center Expansion

CompanyDrug

Ascentage Pharma’s APG-5918 Receives FDA Approval for First-in-Human Study

CompanyDeals

Luzhu Bio Files for Hong Kong IPO After RMB 4.42 Billion Valuation

CompanyDeals

Youwe Bio’s Series B Financing to Advance Microneedle Technology Commercialization

Policy / Regulatory

NHSA Updates NRDL with Focus on Expert Review and Simplified Renewals

CompanyDrug

Ascletis Pharma Doses First Patient in China’s Phase II Trial for HIV-1 Treatment with ASC22

CompanyDrug

Jixing Pharmaceuticals’ Aficamten Receives CDE Approval for Phase III HCM Study

CompanyDrug

BDgene Advances CRISPR-Based BD111 for Herpes Keratitis with IND Filing

CompanyDeals

MicroPort NeuroTech Lists in Hong Kong with $43.3 Million IPO